ClinicalTrials.govpublic full text
The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients
platelet aggregation inhibitors, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979075
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.